Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravitreal ranibizumab vs macular grid-pattern laser for diabetic macular edema
2008-007232-18Phase 3Completed
- Sponsor
- University of Szeged
- Start
- Feb 2009
- Modality
- Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of ranibizumab in diabetic macular edema (DME) (2 arms), sponsored by University of Szeged. Primary endpoints: Change in best-corrected visual acuity (BCVA) and Change in retinal thickness. Started Feb 2009; status: completed.
02
Drugs
ranibizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on 2008-007232-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007232-18.